Ammara A Watkins1, Tara S Kent1, William E Gooding2, Ugo Boggi3, Sri Chalikonda4, Michael L Kendrick5, R Matthew Walsh4, Herbert J Zeh6, A James Moser7. 1. Pancreas and Liver Institute, Beth Israel Deaconess Medical Center, Boston, MA, USA. 2. The University of Pittsburgh Cancer Institute Biostatistics Facility, Pittsburgh, PA, USA. 3. University of Pisa, Pisa, Italy. 4. Departments of Surgery, Cleveland Clinic Foundation, Cleveland, OH, USA. 5. Mayo Clinic, Rochester, MN, USA. 6. University of Pittsburgh Medical Center, Pittsburgh, PA, USA. 7. Pancreas and Liver Institute, Beth Israel Deaconess Medical Center, Boston, MA, USA. Electronic address: ajmoser@bidmc.harvard.edu.
Abstract
BACKGROUND: Perceived excess morbidity during the early learning curve of minimally-invasive pancreaticoduodenectomy (MIPD) has limited widespread adoption. It was hypothesized that robot-assisted reconstruction (RA) after MIPD allows anastomotic outcomes equivalent to open pancreaticoduodenectomy (PD). METHODS: Intent to treat analysis of centrally audited data accrued during early adoption of RA-MIPD at five centers. RESULTS: CUSUM analysis of operating times at each center identified 92 RA-MIPD during the early learning curve. Mean age was 65 ± 12 years with body mass index 25.8 ± 5.0. Surgical indications included malignant (60%) and premalignant (38%) lesions. Median operating time was 504 min (interquartile range 133) with 242 ml median estimated blood loss (IQR 398) and twelve (13%) conversions to open PD. Major complication rate (Clavien-Dindo III/IV) was 24% with 2 (2.2%) deaths and ten (10.9%) reoperations. Nine (9.9%) clinically significant pancreatic fistulae were observed (4 grade B; 5 grade C). Margin negative resection rate for malignancy was 90% (75% for PDA) with mean harvest of 16 ± 8 lymph nodes. CONCLUSIONS: These multicenter data during the early learning curve for RA-MIPD do not demonstrate excess anastomotic morbidity compared to open. Further studies are required to determine whether surgeon proficiency and evolving technique improve anastomotic outcomes compared to open.
BACKGROUND: Perceived excess morbidity during the early learning curve of minimally-invasive pancreaticoduodenectomy (MIPD) has limited widespread adoption. It was hypothesized that robot-assisted reconstruction (RA) after MIPD allows anastomotic outcomes equivalent to open pancreaticoduodenectomy (PD). METHODS: Intent to treat analysis of centrally audited data accrued during early adoption of RA-MIPD at five centers. RESULTS: CUSUM analysis of operating times at each center identified 92 RA-MIPD during the early learning curve. Mean age was 65 ± 12 years with body mass index 25.8 ± 5.0. Surgical indications included malignant (60%) and premalignant (38%) lesions. Median operating time was 504 min (interquartile range 133) with 242 ml median estimated blood loss (IQR 398) and twelve (13%) conversions to open PD. Major complication rate (Clavien-Dindo III/IV) was 24% with 2 (2.2%) deaths and ten (10.9%) reoperations. Nine (9.9%) clinically significant pancreatic fistulae were observed (4 grade B; 5 grade C). Margin negative resection rate for malignancy was 90% (75% for PDA) with mean harvest of 16 ± 8 lymph nodes. CONCLUSIONS: These multicenter data during the early learning curve for RA-MIPD do not demonstrate excess anastomotic morbidity compared to open. Further studies are required to determine whether surgeon proficiency and evolving technique improve anastomotic outcomes compared to open.
Authors: Cho Rok Lee; Seoung Yoon Rho; Sang Hyup Han; Young Moon; Sun Young Hwang; Young Joo Kim; Chang Moo Kang Journal: World J Surg Date: 2019-11 Impact factor: 3.352
Authors: Charlotte Friederieke Müller-Debus; Michael Thomaschewski; Markus Zimmermann; Ulrich F Wellner; Dirk Bausch; Tobias Keck Journal: Visc Med Date: 2020-03-17
Authors: Carl R Schmidt; Britney R Harris; Kelsey A Musgrove; Pavan Rao; J Wallis Marsh; Alan A Thomay; Melissa E Hogg; Herbert J Zeh; Amer H Zureikat; Brian A Boone Journal: J Surg Oncol Date: 2020-11-02 Impact factor: 3.454
Authors: Maria Luisa Brandi; Sunita K Agarwal; Nancy D Perrier; Kate E Lines; Gerlof D Valk; Rajesh V Thakker Journal: Endocr Rev Date: 2021-03-15 Impact factor: 19.871